Moreover, correction for multiple comparisons revealed statistically significant differences in the levels of CAPN10 tv3, CDK5 tv1, CDK5 tv2, CDKN2A tv3, CDKN2A tv4, and THADA tv5 between controls and T2D patients, and of CAPN10 tv3, CDK5 tv1, CDKN2A tv3, CDKN2A tv4, IGF2BP2 tv7, KCNQ1 tv1 among CTRF−, CTRF+ and T2D subjects. This evidence concerns the gene CAPN10 and type 2 diabetes mellitus.